Le Lézard
Classified in: Environment, Health, Science and technology, Covid-19 virus
Subjects: Photo/Multimedia, Product/Service, Corporate Social Responsibility

Teva Announces New Environmental, Social and Governance (ESG) Strategy and Goals in 2020 Report

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today published its 2020 Environmental, Social and Governance (ESG) Progress Report detailing the company's efforts to advance health and equity, minimize its impact on the planet and dedicate itself to quality, ethics and transparency.

The report highlights new ambitious goals, including launching eight programs to increase access to medicines globally by 2025 and reducing Scope 1 and 2 greenhouse gas emissions by 33% by 2030. These goals are being integrated into Teva's corporate strategy, with some directly linked to executive compensation.

For the first time, the company's ESG Progress Report aligns with the Sustainability Accounting Standards Board (SASB) and Task Force on Climate-Related Financial Disclosures (TCFD). It also includes external verification of additional environmental and employee data.

"Teva's latest ESG Progress Report reflects the importance of health and the healthcare industry," said Kåre Schultz, President & CEO of Teva. "Throughout the COVID-19 pandemic, Teva ensured the uninterrupted supply of our medicines to patients, while protecting our employees, partnering with governments and healthcare organizations, providing potential treatments and helping to distribute vaccines and tests. With our collective progress, new goals and enhanced reporting, 2020 cemented ESG as integral to our company's long-term sustainability and resilience."

In collaboration with partners, patients, communities and governments, Teva's ESG achievements in 2020 included:

This progress reflects Teva's improved ESG performance, which was recognized in key indices last year. S&P Global ranked Teva in the top 30% of pharmaceutical companies?a 15% increase from 2019?and Sustainalytics ranked Teva in the top 10% of pharmaceutical companies. The company's CDP climate change score improved from B to A- as a result of its greenhouse gas emissions reduction initiatives, and Teva was the second ranked generics company in the Access to Medicine Foundation's Antimicrobial Resistance Benchmark.

"ESG is everyone's business at Teva, and this report reflects our employees' cumulative contributions," says Mark Sabag, EVP, HR, GCB at Teva. "Our renewed ESG strategy authentically represents our commitments to the communities in which we live and the patients we serve."

In its 120th year, Teva remains dedicated to supporting the needs of communities, employees and patients?maintaining an ESG mindset as it delivers quality medicines to nearly 200 million people every day. Read more about Teva's 2020 ESG Progress Report here.

About Teva

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has been developing and producing medicines to improve people's lives for more than a century. We are a global leader in generic and specialty medicines with a portfolio consisting of over 3,500 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day, and are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of specialty and biopharmaceutical products. Learn more at www.tevapharm.com.

Cautionary Note Regarding Forward-Looking Statements

This 2020 Environmental, Social and Governance Progress Report contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on management's current beliefs and expectations and are subject to substantial risks and uncertainties, both known and unknown, that could cause our future results, performance or achievements to differ significantly from that expressed or implied by such forward-looking statements. Important factors that could cause or contribute to such differences include risks relating to:

and other factors discussed in our Annual Report on Form 10-K for the year ended December 31, 2020, and subsequent SEC filings, including in the sections captioned "Risk Factors" and "Forward Looking Statements." Forward-looking statements speak only as of the date on which they are made, and we assume no obligation to update or revise any forward-looking statements or other information contained herein, whether as a result of new information, future events or otherwise. You are cautioned not to put undue reliance on these forward-looking statements.

These press releases may also interest you

at 15:25
Sealed Air Corporation ("Sealed Air") today announced the total consideration (the "Total Consideration") relating to its previously announced cash tender offer (the "Tender Offer") for any and all of its 4.500% senior notes due 2023 (the "Notes")...

at 15:20
The "Research Report on China's Rare Earth Permanent Magnets Export 2023-2032" report has been added to  ResearchAndMarkets.com's offering.   Rare earth permanent magnetic material is a magnetic material with strong magnetic properties and...

at 14:50
The "Global Automotive Parts Remanufacturing Market - Analysis By Component, By Vehicle (PV, LCV, HCV, ATV, ORV), By Region, By Country: Market Size, Insights, Competition, Covid-19 Impact and Forecast (2023-2028)" report has been added to...

at 14:10
The "Global Genetic Toxicology Testing Market Size, Share & Industry Trends Analysis Report by Product, Type, Application (Pharmaceutical & Biotechnology, Food Industry, Cosmetics Industry), Regional Outlook and Forecast, 2022-2028" report has been...

at 14:07
[email protected], the oncology unit of Eli Lilly and Company , today announced that the U.S....

at 14:05
Lavoro, Brazil's largest agricultural input retailer, continues its expansion in Latin America with the acquisition of a majority stake of Cromo Química, based in Estrela, Rio Grande do Sul, Brazil. The acquisition will put Cromo Química within the...

News published on 5 may 2021 at 08:05 and distributed by: